Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Pushes for Increased DXA Reimbursement

Linda Childers  |  June 19, 2019

Broken hips are among the most serious injuries incurred by older adults, and many fractures are preventable. According to the Centers for Disease Control and Prevention (CDC), approximately 300,000 people over the age of 65 are hospitalized each year for hip fractures, with women (who have lower bone density than men) experiencing three-quarters of all hip fractures.

The Issue at Hand
Although dual-energy X-ray absorptiometry (DXA) is considered the gold standard in measuring bone density, diagnosing osteoporosis and helping prevent fractures, many physicians are finding it cost prohibitive to offer this service in their private practice.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The [CMS] has cut DXA reimbursement in the private practice setting by more than 75% since 2007,” says Chris Phillips, MD, a rheumatologist in private practice in Paducah, Ky., and chair of the ACR’s Insurance Subcommittee. “The rate was $140 in 2007 and dropped to $42 in 2018.”

The ACR’s Response
Dr. Phillips and other members of the ACR have attended advocacy meetings in Washington, D.C., to support legislation for the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (H.R. 2693/S. 283). If passed, this would set the minimum for Medicare reimbursement at $98, ensuring bone density testing can be performed for more patients. The CMS has raised the reimbursement rate for DXA testing in the hospital setting, but the ACR would like to see rates raised in the private practice setting as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s currently not cost effective for many physicians to replace older DXA machines when they break,” Dr. Phillips says. “We once had 22,000 DXA providers; today, there are less than 16,000. This can make testing difficult for patients who live in a rural area and don’t have easy access to a hospital.” 

Why It’s Important
Dr. Phillips notes that raising reimbursement rates makes sense, because fractures in older adults often result in poor medical outcomes. A recent study found that one in three adults age 50 and older dies within 12 months of suffering a hip fracture.

“We’ve seen a 50% decline in DXA testing over the past decade,” says Ken Saag, MD, MSc, a rheumatologist in Birmingham, Ala., current ACR secretary and past president of the National Osteoporosis Foundation. As DXA testing has declined, doctors have seen an increase in the number of hip fractures reported among older adults. “Hip fracture rates had been on the decline, but in 2013, hip fracture rates leveled off and in some age groups, were even higher,” says Dr. Saag.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Dr. Chris Phillipsdual-energy X-ray absorptiometry (DXA)DXA reimbursement cutsFractureship fractureIncreasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)Ken Saag

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Prevent Osteoporotic Fractures with a Fracture Liaison Service

    May 18, 2019

    Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences